The Finnish pharmaceuticals in dosage market has shown considerable fluctuations over the past decade. In 2023, the market value stood at USD 4.941 billion. Key trends indicate a declining market with year-on-year variations showing decreases of 2.49% in 2022 and 2.53% in 2023. The 5-year CAGR leading up to 2023 is calculated at -2.14%, illustrating a consistent downward trend.

The forecasted data from 2024 to 2028 project a further decline in market value, with a 5-year CAGR of -2.15% and an overall reduction of 10.28% in market size over this period. This suggests ongoing market contraction.

Future trends to watch for include:

The impact of technological advancements in drug formulation and delivery
Changes in healthcare policies and regulations in Finland
Potential for market consolidation as companies aim to optimize resources amid declining revenues
Growing emphasis on personalized medicine and its effect on traditional pharmaceuticals.